LEAP2 and Alzheimer disease: Although we cannot completely refute a possible contribution of Aβ to hippocampal ghrelin signaling dysfunction in aging brains, this issue is complicated by the close association of an increased LEAP2/ghrelin molar ratio with chronological age, as the incidence of AD is augmented with age (77).